Exelixis (EXEL) Stock Nɛnɛya
Dernier prix$58.18Sɔrɔli 25 Sep 2026 19:59 UTC
Variation+0.41%
Prévision IA: EXEL
AI bɛ sɔrɔli kɔrɔtɔli sɔrɔ sisan kɔnɔ, kɔnɔ sɔrɔli ni kɔnɔ sɔrɔli. Bɛnɛya bɛ sɔrɔ kɔnɔ sɔrɔli kɔnɔ. O bɛɛ bɛ sɔrɔ ni statistiki, a tɛ jɛya kɔrɔtɔli.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA à 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Débloquer Premium🔒 Nɛnɛya kɔrɔtɔli sɔrɔli
Nɛnɛya kɔrɔtɔli sɔrɔli — nɛnɛya bɛɛ ni kɔnɔ sɔrɔli — bɛ Premium kɔnɔ.
Débloquer PremiumƝɛnɛ kɔnɔ bɛnɛ
Exelixis, Inc. is a biotechnology company specializing in the development of promising small-molecule drugs for the treatment of cancer and other serious diseases, including kidney disease, thyroid cancer, and advanced melanoma. The company also establishes strategic partnerships with other pharmaceutical and biotechnology firms.
